Screener
Candel Therapeutics, Inc. CADL Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Candel Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-222904
FAQ
- What is Candel Therapeutics, Inc.'s book value per share?
- Candel Therapeutics, Inc. (CADL) reported book value per share of $2.21 in Q1 2026.
- How has Candel Therapeutics, Inc.'s book value per share changed year-over-year?
- Candel Therapeutics, Inc.'s book value per share increased by 62.3% year-over-year, from $1.36 to $2.21.
- What is the long-term trend for Candel Therapeutics, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Candel Therapeutics, Inc.'s book value per share has grown at a -13.5% compound annual growth rate (CAGR), from -$2.03 to $0.98.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Candel Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude